The Scientific Advisory Group of the Association of Racing Commissioners International (ARCI) has reported that there is no current science linking furosemide treatments to muscular skeletal issues that may be a contributing cause of equine breakdowns in racing, according to a press release from ARCI Wednesday.
The group reported to a meeting of the RCI's Drug Testing Standards and Practices Committee that they discussed the issue at their meeting Apr. 2 and were not aware of any published studies or papers providing any evidence of such a link.
“There remains an attempt on the part of some organizations and individuals to leave the impression that the current equine welfare policy of permitting the voluntary race day use of furosemide under controlled and transparent circumstances is somehow tied to the tragic equine deaths that have occurred at Santa Anita and elsewhere,” said ARCI President Ed Martin in a statement.
Not a subscriber? Click here to sign up for the daily PDF or alerts.
